4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-18-000008
Chief Executive Officer gave up 46,048 shares (to pay taxes)
- Chief Executive Officer acquired 163,033 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kim Jong Joseph · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-09 | Exercise or conversion : show line 1 in the form | +57,333 | 2,232,155 | D | ||
| 2018-03-09 | Shares withheld for taxes : show line 2 in the form | −15,944 | $4.51 | $71,907 | 2,216,211 | D |
| 2018-03-10 | Exercise or conversion : show line 3 in the form | +105,700 | 2,321,911 | D | ||
| 2018-03-10 | Shares withheld for taxes : show line 4 in the form | −30,104 | $4.51 | $135,769 | 2,291,807 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2018-03-09 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −57,334 | 57,333 | 57,333 | D |
| 2018-03-10 | Exercise or conversion : show line 6 in the form Restricted Stock Unit | −105,700 | 105,700 | 211,400 | D |
Loading xslF345X03/wf-form4_152098044956325.xml…